LUMINOPIA
Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product, Luminopia One, to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com.
LUMINOPIA
Industry:
Health Care Medical Virtual Reality
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.luminopia.com
Total Employee:
1+
Status:
Active
Contact:
1 833-458-6466
Email Addresses:
[email protected]
Total Funding:
11.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Apache Cloudflare JS CDN JS JQuery CDN
Similar Organizations
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Oxford Endovascular
Oxford Endovascular are developing a novel treatment for treating brain aneurysms.
Vicarious Surgical
Vicarious Surgical is a robotics company that develops robotic systems that allow surgeons to perform minimally invasive surgery.
Current Advisors List
Current Employees Featured
Founder
Investors List
NXT Ventures
NXT Ventures investment in Seed Round - Luminopia
Bantam Group
Bantam Group investment in Pre Seed Round - Luminopia
Sesame Ventures
Sesame Ventures investment in Pre Seed Round - Luminopia
MassChallenge
MassChallenge investment in Angel Round - Luminopia
Official Site Inspections
http://www.luminopia.com Semrush global rank: 7.73 M Semrush visits lastest month: 437
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Luminopia"
Luminopia - Crunchbase Company Profile & Funding
Luminopia Treatment: A VR-based treatment for amblyopia in children aged 4-7, using a dual-acting binocular mechanism to improve vision by encouraging …See details»
Luminopia Binocular Therapy for Amblyopia
Luminopia has been shown to improve visual clarity in amblyopia (lazy eye) patients, aged 4-7, associated with vision imbalance and/or with mild crossed eye. Luminopia is intended to be …See details»
What is Luminopia?
The following Luminopia products, either alone or in combination with other products, are protected by one or more of the identified patents. The absence of a product name or patent number …See details»
Luminopia 2025 Company Profile: Valuation, Funding …
Luminopia was founded in 2016. Where is Luminopia headquartered? Luminopia is headquartered in Cambridge, MA. What is the size of Luminopia? …See details»
Luminopia, Inc. Company Profile | Cambridge, MA | Competitors ...
Find company research, competitor information, contact details & financial data for Luminopia, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Luminopia Company Profile - Office Locations, Competitors ... - Craft
Luminopia has 5 employees at their 1 location and $16 m in total funding,. See insights on Luminopia including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Luminopia, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Luminopia meets rigorous criteria set by Highmark's New Technology Advisory Committee (NTAC) and receives a positive coverage determination from the plan CAMBRIDGE, Mass., …See details»
Luminopia - Contacts, Employees, Board Members, Advisors
Organization. Luminopia . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... About. Luminopia has 4 current employee profiles, …See details»
Pentec Expands into Digital Therapeutic Services Through …
9 hours ago Luminopia's flagship product, Luminopia ®, is the first FDA-approved 2 prescription digital therapeutic for amblyopia, commonly known as "lazy eye,” the most common cause of …See details»
Luminopia - VentureRadar
By leveraging mobile VR technologies, perceptual learning and eye training, Luminopia has created an unparalleled, proprietary treatment device that is safe, fun, and fast in order to …See details»
Luminopia for Healthcare Professionals
Luminopia is the simple, engaging and effective FDA-approved* amblyopia treatment designed to improve vision in children 4-7 years old. 1-3 By prescribing Luminopia, you’re giving patients …See details»
Luminopia Adherence Portal
The Luminopia Adherence Portal allows healthcare professionals to monitor patient progress and manage accounts.See details»
Understanding Digital Treatments for Amblyopia
Sep 24, 2024 Luminopia Results. Luminopia uses reduced contrast to the nonamblyopic eye and blocking of complementary areas of the image to each eye. The Luminopia Pivotal Trial …See details»
Patient Support - Luminopia
Luminopia has been shown to improve visual clarity in amblyopia (lazy eye) patients, aged 4-7, associated with vision imbalance and/or with mild crossed eye. Luminopia is intended to be …See details»
How Luminopia Uses VR To Make Amblyopia Treatment …
Nov 8, 2024 Luminopia makes an FDA-approved binocular therapy that leverages a VR headset to stream children’s shows. The device, designed for children ages 4–7, gives treatment for an …See details»
How four-person startup Luminopia is using TV to treat lazy eye
Oct 1, 2021 Luminopia’s most recently published trial follows a single-arm pilot trial, which evaluated the technology’s at nine sites, and on a total of 84 participants. In the first phase of …See details»
Pentec Expands into Digital Therapeutic Services Through …
9 hours ago Luminopia is intended for both previously treated and untreated patients; however, patients with more than 12 months of prior treatment (other than refractive correction) have not …See details»
Resources - Luminopia
Luminopia has been shown to improve visual clarity in amblyopia (lazy eye) patients, aged 4-7, associated with vision imbalance and/or with mild crossed eye. Luminopia is intended to be …See details»
Luminopia scores FDA approval for TV-based amblyopia therapy
1 day ago Luminopia One can now be prescribed to improve visual acuity in children aged 4-7 with amblyopia associated with mild strabismus – or crossed eyes – and/or a condition called …See details»
Luminopia FDA-Approved Medical Device Treatment for Amblyopia
Luminopia has been shown to improve visual clarity in amblyopia (lazy eye) patients, aged 4-7, associated with vision imbalance and/or with mild crossed eye. Luminopia is intended to be …See details»